Skip to main content
驱动力 logo

驱动力 — Investor Relations & Filings

Ticker · 920275 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 479 across all filing types
Latest filing 2022-04-27 Proxy Solicitation & In…
Country CN China
Listing Beijing Stock Exchange 920275

About 驱动力

https://www.chinaedrive.com/

Drive Power Bio-tech specializes in the research, development, and manufacturing of functional additives designed for animal nutrition. The company focuses on hematopoietic technology, providing solutions that enhance hemoglobin synthesis, strengthen immune responses, and support intestinal health. Its product portfolio includes specialized nutritional supplements that optimize metabolic processes and improve growth performance. By leveraging biotechnological innovation, the company develops high-efficiency additives aimed at enhancing physiological health and production efficiency in large-scale agricultural environments.

Recent filings

Filing Released Lang Actions
关于独立董事公开征集投票权公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement regarding the solicitation of voting rights by independent directors for a specific shareholders' meeting (the 2022 second extraordinary general meeting). It includes information about the meeting date, agenda items related to a stock incentive plan, procedures for proxy voting, and legal assurances by the independent directors. There is no financial data, earnings information, or report content. The document is not a report itself but an announcement related to voting and proxy solicitation for a shareholders' meeting. This fits the category of Proxy Solicitation & Information Statement (PSI). The document length is under 5,000 characters, but it contains detailed procedural and voting information, not just a brief announcement, so it is not a Report Publication Announcement (RPA).
2022-04-27 Chinese
2022年股权激励计划授予的激励对象名单
Director's Dealing Classification · 95% confidence The document is a company announcement detailing the allocation of stock options under an incentive plan to various executives and core employees. It includes specific numbers of stock options granted, percentages relative to the total incentive plan, and the company's board approval status. There is no indication of financial statements, audit results, or regulatory certifications. The content focuses on management stock option grants, which is related to insider or director dealings in shares. Given the nature of the document—reporting personal share transactions or allocations to directors and senior management—it fits best under the category of Director's Dealing (DIRS). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Therefore, the classification is DIRS with high confidence.
2022-04-27 Chinese
华安证券股份有限公司关于广东驱动力生物科技股份有限公司2022年股权激励计划（草案）之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" regarding the 2022 Equity Incentive Plan (Draft) of Guangdong Driving Force Biotechnology Co., Ltd. It is prepared by Huaan Securities Co., Ltd. The content includes detailed descriptions of the equity incentive plan, including purpose, number of shares/options granted, eligibility, vesting periods, exercise prices, performance conditions, and procedures. The document is a comprehensive advisory report on a stock option incentive plan, which is a form of equity compensation plan. It is not a general annual or quarterly financial report, nor is it an earnings release or a regulatory filing announcement. It is also not a proxy statement or voting results announcement. The document is a standalone advisory report related to a specific equity incentive plan, which fits the category of Audit Report / Information (AR) as it involves independent financial advisor's opinions and verification related to the equity incentive plan, including accounting treatment and valuation methods. The length (15,000 characters) and detailed content confirm it is the full report, not just an announcement or summary. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2022
2022-04-27 Chinese
关于召开2022 年第二次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2022 second extraordinary general meeting of shareholders for Guangdong Drive Biological Technology Co., Ltd. It details the meeting date, voting methods, agenda items including stock option incentive plans, core employee nominations, company name change proposal, and amendments to the articles of association. It does not contain financial statements or results but is a formal announcement of a shareholders meeting and its agenda. The document length is 4517 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2022-04-27 Chinese
关于拟变更公司名称的公告
Board/Management Information Classification · 95% confidence The document is an announcement from the company's board regarding a proposed change of the company name and amendments to the company bylaws. It includes details about the board meeting, voting results, and the planned timeline for the name change registration. There is no financial data, audit information, or report attached. The content focuses on corporate governance decisions and board resolutions. This fits best under Board/Management Information (MANG) as it announces changes related to company governance and structure, specifically the company name change and board resolutions.
2022-04-27 Chinese
北京市中伦（广州）律师事务所关于广东驱动力生物科技股份有限公司2022年股权激励计划的法律意见书
Regulatory Filings
2022-04-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.